Blog: Blog2

GPCR News

Jul 31, 20221 min read

SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...

August 2022 "We are proud to announce that SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...

Jun 30, 20221 min read

G.CLIPS biotech is 2 years old this month!

July 2022 "G.CLIPS biotech is 2 years old today🎂. When I came this morning to work this is how I found my desk. So very grateful to the...

May 31, 20221 min read

GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development

June 2022 "We’re delighted to welcome Dr Ed Brennan as our new Vice President, Head of Clinical Development. Dr Brennan has extensive...

Feb 28, 20221 min read

Exscientia welcomes Richard J. Law, as their new Chief Business Officer

March 2022 "Congratulations to Richard J. Law, our newly named Chief Business Officer. Richard is the architect behind nearly all of...

Jan 31, 20221 min read

AELIS PHARMA launches their IPO for €25 million

February 2022 "We are proud to announce the success of our IPO! Thank you to our shareholders, both historical and new, for their trust....

Jan 31, 20221 min read

InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...

February 2022 "InterAx Biotech AG and Boehringer Ingelheim take first steps towards collaborating to unlock orphan targets leveraging...